Q1 2025 Management View CEO Kimberly Ryan highlighted the sale of a 51% stake in the Milacron injection molding and extrusion business to Bain Capital for $287 million, retaining a 49% stake. This ...

Industrial processing equipment and solutions provider Hillenbrand (NYSE:HI) beat Wall Street’s revenue expectations in Q4 ...

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...

D.A. Davidson analyst Matt Summerville maintained a Hold rating on Hillenbrand (HI – Research Report) today and set a price target of $33.00.

Industrial processing equipment and solutions provider Hillenbrand (NYSE:HI) will be reporting results tomorrow after market ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Hillenbrand's stock faces challenges due to subdued demand, impairment charges, and high debt. Read why I remain neutral on ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.

Hillenbrand expects full-year earnings in the range of $2.45 to $2.80 per share, with revenue ranging from $2.63 billion to $2.79 billion. This story was generated by Automated Insights ( ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.